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Why did the authors not recommend the use of an 
autologous arterial graft in assessing new experimental 
coronary artery bypass conduits? We submit that autolo- 
gous arterial conduits hould be used as the control graft to 
test new small-caliber vascular grafts in the coronary artery 
position. Arterial conduits, including the internal thoracic 
artery (ITA), gasttoepiploic artery, and inferior epigastric 
artery, have been used clinically in the coronary artery 
position for years, and the ITA has markedly better 
long-term patency rates than saphenous vein grafts. Both 
the ITA and femoral artery autologous grafts have been 
successfully used in the coronary artery position in recent 
short-term canine studies. In the long-term dog experiment 
by Ono et al.,S autologous femoral artery and ITA coronary 
grafts remained patent for more than 6 months. Perfor- 
mance compared with an autogenous arterial control graft 
should be considered as the standard in future experiments 
evaluating new synthetic or biosynthetic coronary bypass 
conduits. 
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Reply 
To the Editors: 
Tomizawa and Noishiki make two points about site 
and nature of the experimental evaluation of new prosthetic 
grafts. I am not sure they have fully understood the study. 
First we maintained that the site of implantation should 
most nearly mimic the site for clinical implantation as much 
as is possible. Thus we recommend and, hence, agree with 
the authors that a graft destined for the coronary position 
should be placed in the aorta to coronary position. Size is 
another important consideration that was not mentioned. 
The issue of control graft material in a comparative 
study was also addressed. The problem involves the 
question being asked. In the "Standard" we considered a 
polytetrafluoroethylene control adequate for a study of a 
graft for the infrainguinal position if the question was 
whether the test graft was equivalent to a clinically relevant 
control. If, however, the question was whether the test 
graft was better than what is available, then the gold 
standard should be used, which, in the instance described, 
is the saphenous vein. I have no disagreement with the 
author's contention that, because there is no prosthetic 
alternative for coronary artery bypass, autogenous vein 
should be the control in studies evaluating new materials 
for heart surgery. 
I invite our Japanese colleagues to carefully reread the 
important cited document to clarify the issues that concern 
them and hope that this reply clarifies any misunderstand- 
ing. I conclude that I find it hard to believe that our Food 
and Drug Administration would ever accept data leading to 
possible human trials for a new prosthesis for coronary 
artery use other than has been specified herein. 
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Changes in arterial wall compliance after 
endovascular stenting 
To the Editors: 
We read with interest he artide by Back et al. (J VASC 
SURG 1994;19:905-11) on their experimental work con- 
cerning compliance changes in a stented canine iliac artery. 
We recently reported our findings in a canine model of an 
aortobiiliac polytetrafluoroethylene bypass graft, in which 
a Wallstent (Schneider Stent Co., St Paul, Minn.) was 
deployed across one distal anastomosis n an attempt o 
control the development ofanastomotic neointimal hyper- 
plasia. ~'2 In our experiments, we measured the arterial 
diameter with a caliper before vessel handling to select an 
appropriately sized stent, and we did not encounter the 
atrophy of the tunica media experienced by Back et al. In 
their study, the diameters of the stented vessels were greater 
than those of the nonstented controls. This raises the 
question about whether oversizing of the stent and 
overdistension f the artery caused the medial atrophy. 
Finally, Back et al. reported finding a neointima of 
uniform thickness associated with the stents. They also 
observed a loss of compliance in the stented portion of the 
vessel. Hence, at the interface of the normal artery and the 
stent, a mismatch of compliance xisted. Because they did 
not encounter a significant accumulation of neointima t 
the stent-to-artery interface, is their work in fact evidence 
